BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16740724)

  • 1. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
    Wen CC; Cheng SA; Hsuen SP; Huang YL; Kuo ZK; Lee HF; Kuo CH; Du JL; Wang WB
    Cancer Res; 2006 Jun; 66(11):5847-57. PubMed ID: 16740724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C; Itamochi H; Yuan LX; Esteva FJ; Wood CG; Terakawa N; Hung MC; Ueno NT
    Cancer Res; 2005 Sep; 65(18):8406-13. PubMed ID: 16166319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.
    Hsueh SP; Hsu WB; Wen CC; Wang WB
    Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal domain of EBNA1 acts as a suppressor of the HER2/neu oncogene.
    Liu JY; Chuang TC; Way TD; Tsai TC; Hu CL; Liu GY; Wang SS; Chung JG; Kao MC
    Cancer Lett; 2009 Jan; 273(2):273-80. PubMed ID: 18805633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene.
    Lin YC; Peng JM; Wang WB
    Oncogene; 2000 May; 19(22):2704-13. PubMed ID: 10851070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
    Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu.
    Roh H; Pippin J; Drebin JA
    Cancer Res; 2000 Feb; 60(3):560-5. PubMed ID: 10676637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV40 T/t-common polypeptide enhances the sensitivity of HER2-overexpressing human cancer cells to anticancer drugs cisplatin and doxorubicin.
    Hsueh SP; Du JL; Hsu WB; Fang CA; Liu H; Wang WB
    Cancer Lett; 2012 Nov; 324(1):48-57. PubMed ID: 22546288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
    J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene.
    Kao MC; Liu GY; Chuang TC; Lin YS; Wuu JA; Law SL
    Oncogene; 1998 Jan; 16(4):547-54. PubMed ID: 9484845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer.
    Xing X; Matin A; Yu D; Xia W; Sorgi F; Huang L; Hung MC
    Cancer Gene Ther; 1996; 3(3):168-74. PubMed ID: 8725881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
    Tuna M; Chavez-Reyes A; Tari AM
    Oncogene; 2005 Feb; 24(9):1648-52. PubMed ID: 15674342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H; Qin H; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):370-3. PubMed ID: 11778270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT; Bartholomeusz C; Herrmann JL; Estrov Z; Shao R; Andreeff M; Price J; Paul RW; Anklesaria P; Yu D; Hung MC
    Clin Cancer Res; 2000 Jan; 6(1):250-9. PubMed ID: 10656456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth.
    Zhang Y; Yang HY; Zhang XC; Yang H; Tsai M; Lee MH
    Oncogene; 2004 Sep; 23(42):7132-43. PubMed ID: 15273726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin.
    Zhang L; Hung MC
    Oncogene; 1996 Feb; 12(3):571-6. PubMed ID: 8637714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
    Brodowicz T; Kandioler D; Tomek S; Ludwig C; Rudas M; Kunstfeld R; Koestler W; Hejna M; Budinsky A; Wiltschke C; Zielinski CC
    Br J Cancer; 2001 Nov; 85(11):1764-70. PubMed ID: 11742500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.